Table 3: Cardiovascular effects of anti-diabetic drugs
Cardiovascular events represent the greatest complication of diabetes. Evidence suggests that metformin improves CV outcomes in patients with diabetes, especially in the United Kingdom Prospective Diabetes Study (UKPDS) and other subsequent studies, by different mechanisms. There are few cardiova...
Main Authors: | Pablo Javier Avila, Silvana Milrad, Mariano Forlino, Sofía Fabregues, Fabiana Vázquez, Cristina Grosso, Ana Schindler, Fabio Zambon, María Virginia Rodríguez, Natalia Carolina Garrido Santos, Laura Calvo, Alejandra Maldini, Sandra Maserati, Romina Stagno |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Sello Editorial Lugones
2020-09-01
|
Series: | Revista de la Sociedad Argentina de Diabetes |
Subjects: | |
Online Access: | https://revistasad.com/index.php/diabetes/article/view/253 |
Similar Items
-
Uso inicial de insulina en pacientes hospitalizados con diabetes mellitus tipo 2
by: John Jaime Sprockel Díaz, et al.
Published: (2022-01-01) -
P49 Metabolic control in patients with diabetes mellitus and obesity. Antidiabetic treatment vs bariatric surgery
by: Felisa Vilches, et al.
Published: (2020-11-01) -
TRATAMIENTO DE LA DIABETES EN EL EMBARAZO: ¿ALGO NUEVO?
by: DRA. Gloria López S.
Published: (2016-03-01) -
Current medical treatment of diabetes type 2 and long term morbidity: how to balance efficacy and safety?
by: C. A. Carrera Boada, et al. -
CELULLAR DRUGS TRANSPORTERS. THE JOURNEY OF THE ORAL ANTIDIABETICS AGENTS TROUGH THE ORGANISM
by: Héctor Alejandro Serra, et al.
Published: (2018-03-01)